BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 25, 2025
Home » Authors » John Brosky

Articles by John Brosky

Report from Europe: Sanofi readies micro-injection device for influenza vaccines

Jan. 14, 2010
By John Brosky

ICD/CRT use in Europe said to have doubled since 2004

Jan. 1, 2010
By John Brosky

No sign of crisis for medtech evident as Medica turns 40

Jan. 1, 2010
By John Brosky

Report from Europe: French IVD leader wins fresh capital, new management

Dec. 3, 2009
By John Brosky

Report from Europe: ICD/CRT use in Europe said to have doubled since 2004

Dec. 2, 2009
By John Brosky

Competition in ultrasound market reshaping sector

Nov. 30, 2009
By John Brosky
DÜSSELDORF, Germany – The economic downturn that has stalled decisions on capital outlay for the big ticket machines of radiology is benefitting a rapidly shifting market for ultrasound that is expected to grow by 15% each year from almost $3 billion in 2008 to over $5 billion by 2012. (Medical Device Daily)
Read More

Seegene accelerates H1N1 screening with new kits

Nov. 25, 2009
By John Brosky
For influenza testing as the H1N1 virus rises to pandemic levels, there is the first-to-market advantage and then there is, well, not much for all the rest. Moving quickly since guidelines were released by the World Health Organization (WHO) in August, 2009, the Korean company Seegene (Bangyi-Dong, South Korea) was able to present at the Medica trade fair held here last week a real-time, high volume rapid test for the four pathogen assays required by guidelines. (Medical Device Daily)
Read More

Wii for healthcare could take motion game to a new level

Nov. 24, 2009
By John Brosky
DÜSSELDORF, Germany – Motion detecting is more than just fun and games. The technology behind the popular Wii from Nintendo is "pretty lightweight technology," according to Marc Attia who directs sales for Movea (Grenoble), who suggests there is a lot more science, and especially clinically useful information, that can be extracted from monitoring the activities of patients. (Medical Device Daily)
Read More

European product focus advances the expansion of Welch Allyn

Nov. 23, 2009
By John Brosky
DÜSSELDORF, Germany — Just as a great chess game can begin with the advance of a modest pawn, the CEO of Welch Allyn (Skaneateles Falls, New York), Julie Shimer rolled forward the new CP 50, a transportable electrocardiograph (ECG) that represents the leading edge of the company's ambitious plans for international expansion. (Medical Device Daily)
Read More

'Smart' patient monitoring needed to improve workflow, safety issues

Nov. 20, 2009
By John Brosky
Previous 1 2 … 57 58 59 60 61 62 63 64 65 … 101 102 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing